• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Recent Advances in the Study of 3,6-Dichlorogentisic Acid (CAS: 18688-01-2): A Comprehensive Research Brief

3,6-Dichlorogentisic Acid (CAS: 18688-01-2) is a chlorinated derivative of gentisic acid, which has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its role as an intermediate in the synthesis of bioactive compounds, its antioxidant properties, and its potential as an anti-inflammatory agent. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug development.

One of the most notable advancements in the study of 3,6-Dichlorogentisic Acid is its application in the synthesis of novel pharmaceutical agents. Researchers have demonstrated its utility as a building block for the development of compounds with enhanced bioactivity. For instance, a recent study published in the Journal of Medicinal Chemistry utilized 3,6-Dichlorogentisic Acid as a precursor to synthesize a series of derivatives with improved antioxidant and anti-inflammatory properties. The study reported that these derivatives exhibited significant scavenging activity against reactive oxygen species (ROS), suggesting their potential in treating oxidative stress-related diseases.

In addition to its role in drug synthesis, 3,6-Dichlorogentisic Acid has been investigated for its direct biological effects. A 2023 study in the European Journal of Pharmacology explored its anti-inflammatory mechanisms, revealing that the compound inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6 in macrophage cells. This finding underscores its potential as a lead compound for developing new anti-inflammatory therapies. Furthermore, the study highlighted the compound's low cytotoxicity, which is a critical factor for its translational potential.

The chemical stability and solubility of 3,6-Dichlorogentisic Acid have also been subjects of recent research. A team of chemists from the University of Cambridge conducted a detailed analysis of its physicochemical properties, including its pKa values and partition coefficients. Their findings, published in the Journal of Chemical & Engineering Data, provide valuable insights into the compound's behavior under various conditions, which is essential for optimizing its formulation in pharmaceutical products.

Despite these promising developments, challenges remain in the widespread application of 3,6-Dichlorogentisic Acid. For example, its synthesis often requires multi-step processes that can be costly and time-consuming. Recent efforts have focused on developing more efficient synthetic routes, such as catalytic chlorination methods, to address this issue. A 2024 study in Organic Process Research & Development reported a novel one-pot synthesis approach that significantly improved the yield and purity of the compound, paving the way for its large-scale production.

In conclusion, 3,6-Dichlorogentisic Acid (CAS: 18688-01-2) represents a versatile and promising compound in the field of chemical biology and pharmaceutical research. Its diverse biological activities, coupled with recent advancements in its synthesis and characterization, make it a valuable candidate for further investigation. Future studies should focus on elucidating its mechanisms of action in greater detail and exploring its potential in clinical applications. This research brief underscores the importance of continued investment in the study of this compound to unlock its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)